Replies to post #438431 on NorthWest Biotherapeutics Inc (NWBO)

[Bright Boy]

Apologies to my good friend Bio for not including him with ATL !! And of course, Doc, "The Dude" from Denmark, Poor Man and all the other great posters on this board !!! It's like a million, piece puzzle and everyone has most of the pieces in place but no one, even Linda or Les have the position of the last few pieces, because they are being told where those pieces fit by the RA's!!!

Mental midgets like AF have zero influence on SP. They only give the MM's an excuse to "downdraft" the SP and steal stock from weak longs!!!

That's my story and I'm sticking to it!!!:):):)

Cheers,

BB

[biosectinvestor]

Note also a little more than a year before the German “temporary halt” that turned out to be a partial halt, the Germans gave the Hospital Exemption:

https://nwbio.com/nw-bio-announces-two-german-approvals-hospital-exemption-for-early-access-program-with-dcvax-l-and-eligibility-of-dcvax-l-for-reimbursement/

It’s a very thorough process. You do not get this if they think your drug is no good. The program does not work well, but still, they heavily review the product it was not intended as a give away but similar to an early access program where it was intended that the creator of the treatment would be paid. The qualifications once you get the designation though, just are not practical. So the German program has pretty much failed.

[Locknload56]

NW Bio is currently conducting a 348-patient Phase III clinical trial of DCVax-L for newly diagnosed GBM patients, in both the US and Europe. In two early stage trials, prior to the current Phase III trial, patients with newly diagnosed GBM who were treated with DCVax-L showed median survival of 3 years. With current standard of care (surgery, radiation and chemotherapy) median survival for such patients is about 14.6 months.

How about German contacts? Anyone know anyone in the medical community there to get their opinion?

[dmb2]

biosectinvestor, do you think the partial clinical hold was due to German ethics regarding placebo arms in trials only, or, the former in addition to seeing positive treatment signals? I did not think Germany does not permit placebo arms in testing drugs in terminal illnesses but I can understand if Germany is faster to draw the line, maybe for the reason you state.

GL